scispace - formally typeset
X

Xiao-Fang Che

Researcher at Tokyo Medical University

Publications -  45
Citations -  1276

Xiao-Fang Che is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 23, co-authored 44 publications receiving 1181 citations. Previous affiliations of Xiao-Fang Che include Kagoshima University.

Papers
More filters
Journal ArticleDOI

Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: Crosstalk among proteasome, autophagy-lysosome and ER stress

TL;DR: Combined treatment with BZ and bafilomycin A1 (BAF), which is a specific inhibitor of vacuolar-ATPase and is used as an autophagy inhibitor at the late stage, resulted in synergistic cytotoxicity, compared with that by either BZ or BAF alone.
Journal ArticleDOI

Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells

TL;DR: Simultaneously targeting two major intracellular protein degradation systems such as the ubiquitin-proteasome system by BZ and the autophagy-lysosomes system by a macrolide antibiotic enhances ER stress-mediated apoptosis in MM cells.
Journal ArticleDOI

Copper-Transporting P-Type ATPase, ATP7A, Confers Multidrug Resistance and Its Expression Is Related to Resistance to SN-38 in Clinical Colon Cancer

TL;DR: It is found that ATP7A transfection of Chinese hamster ovary cells and fibroblasts isolated from Menkes disease patients enhanced resistance not only to CDDP but also to various anticancer drugs, and the trans-Golgi network has an important role of ATP 7A-related drug resistance.